Search results
Added:
1 year ago
AF Symposium 25 - Safety and effectiveness results show the Volt (Abbott) pulsed field ablation (PFA) system for pulmonary vein isolation (PVI) is a successful treatment option for paroxysmal and persistent atrial fibrillation patients.Prof Roland Tilz (University Heart Centre Lübeck, Lübeck, DE) joins us onsite at AF Symposium 25 to discuss the findings of balloon-based PFA for PVI. The pre…
View more
Added:
1 month ago
Source:
Arrhythmia Academy
A new substudy of the VANISH2 trial suggests that for patients with prior myocardial infarction and ventricular tachycardia (VT) who are eligible for sotalol, catheter ablation leads to better outcomes than antiarrhythmic drug (AAD) therapy.¹ For patients eligible only for amiodarone, efficacy was comparable, but amiodarone was associated with a significant increase in adverse events…
View more
Added:
1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and…
View more
Added:
1 year ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125…
View more
Added:
3 months ago
AHA 2025 - Dr Vivek Y Reddy (Icahn School of Medicine at Mount Sinai, New York, US) joins us to share findings from the PFA-SHAM study (NCT05717725) investigating pulsed field ablation (PFA) versus sham ablation to treat AF. Patients enrolled in the study underwent an electrophysiology study to ensure they had no concealed AV bypass tract or supraventricular tachycardia, and patients were then…
View more
Added:
3 weeks ago
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant…
View more
AF Symposium 2025 Late-Breaking Science Collection
Video Series
Added:
11 months ago
EHRA 2025 - SINGLE SHOT CHAMPION finds PFA with the FARAPULSE PFA System noninferior to cryoballoon ablation with the Arctic Front Cryoballoon.Prof Tobias Reichlin (University of Bern, Bern, CH) joins us on-site at EHRA Congress 2025 to discuss the investigator-initiated, multicenter, randomized SINGLE SHOT CHAMPION trial (NCT05534581; Insel Gruppe AG, University Hospital Bern) with blinded…
View more
Added:
1 month ago
Source:
Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular…
View more
EHRA 2024: Late-Breaking Science Video Collection
Added:
1 year ago
Video Series